Clinical Trial Update: Antiglucocorticoid Therapy for Cognitive Impairment in Late-life Anxiety Disorders [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating antiglucocorticoid therapy for cognitive impairment in late-life anxiety disorders has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Cognitive Impairment

Snippet

Sponsor: Washington University School of Medicine | Conditions: Anxiety Disorders | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-03-18